Anionic antimicrobial peptides from eukaryotic organisms F Harris, SR Dennison, DA Phoenix Current Protein and Peptide Science 10 (6), 585-606, 2009 | 376 | 2009 |
Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus M Wainwright, DA Phoenix, SL Laycock, DRA Wareing, PA Wright FEMS microbiology letters 160 (2), 177-181, 1998 | 297 | 1998 |
A study of photobactericidal activity in the phenothiazinium series M Wainwright, DA Phoenix, J Marland, DRA Wareing, FJ Bolton FEMS Immunology & Medical Microbiology 19 (1), 75-80, 1997 | 236 | 1997 |
Type II diabetes mellitus and cardiovascular risk factors: current therapeutic approaches C Kalofoutis, C Piperi, A Kalofoutis, F Harris, D Phoenix, J Singh Experimental & Clinical Cardiology 12 (1), 17, 2007 | 229 | 2007 |
Amphiphilic α-helical antimicrobial peptides and their structure/function relationships SR Dennison, J Wallace, F Harris, DA Phoenix Protein and peptide Letters 12 (1), 31-39, 2005 | 222 | 2005 |
On the selectivity and efficacy of defense peptides with respect to cancer cells. F Harris, SR Dennison, J Singh, DA Phoenix Medical Research Reviews 33, 190-234, 2013 | 202 | 2013 |
Increased cytotoxicity and phototoxicity in the methylene blue series via chromophore methylation M Wainwright, DA Phoenix, L Rice, SM Burrow, J Waring Journal of Photochemistry and Photobiology B: Biology 40 (3), 233-239, 1997 | 200 | 1997 |
Anticancer α-helical peptides and structure/function relationships underpinning their interactions with tumour cell membranes SR Dennison, M Whittaker, F Harris, DA Phoenix Current Protein and Peptide Science 7 (6), 487-499, 2006 | 192 | 2006 |
Phenothiazinium based photosensitisers-photodynamic agents with a multiplicity of cellular targets and clinical applications F Harris, LK Chatfield, DA Phoenix Current drug targets 6 (5), 615-627, 2005 | 156 | 2005 |
Antimicrobial peptides DA Phoenix, SR Dennison, F Harris John Wiley & Sons, 2012 | 153 | 2012 |
The phototoxicity of phenothiazinium derivatives against Escherichia coli and Staphylococcus aureus DA Phoenix, Z Sayed, S Hussain, F Harris, M Wainwright FEMS Immunology & Medical Microbiology 39 (1), 17-22, 2003 | 122 | 2003 |
pH dependent antimicrobial peptides and proteins, their mechanisms of action and potential as therapeutic agents E Malik, SR Dennison, F Harris, DA Phoenix Pharmaceuticals 9 (4), 67, 2016 | 119 | 2016 |
Photobactericidal activity of methylene blue derivatives against vancomycin-resistant Enterococcus spp. M Wainwright, DA Phoenix, M Gaskell, B Marshall Journal of antimicrobial chemotherapy 44 (6), 823-825, 1999 | 113 | 1999 |
Beneficial effect and mechanism of action of Momordica charantia in the treatment of diabetes mellitus: a mini review C Garau, J Singh, P DA, E Cummings International Journal of Diabetes and Metabolism 11, 46-55, 2003 | 106 | 2003 |
Antimicrobial peptides: their history, evolution, and functional promiscuity DA Phoenix, SR Dennison, F Harris Antimicrobial peptides 8, 1-37, 2013 | 102 | 2013 |
The effect of amidation on the behaviour of antimicrobial peptides M Mura, J Wang, Y Zhou, M Pinna, AV Zvelindovsky, SR Dennison, ... European Biophysics Journal 45 (3), 195-207, 2016 | 99 | 2016 |
Calpains: targets of cataract prevention? S Biswas, F Harris, S Dennison, J Singh, DA Phoenix Trends in molecular medicine 10 (2), 78-84, 2004 | 99 | 2004 |
Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology A Elhissi, K Hidayat, DA Phoenix, E Mwesigwa, SJ Crean, W Ahmed, ... International journal of pharmaceutics 444 (1-2), 193-199, 2013 | 82 | 2013 |
Influence of C-terminal amidation on the efficacy of modelin-5 SR Dennison, DA Phoenix Biochemistry 50 (9), 1514-1523, 2011 | 80 | 2011 |
The effect of C-terminal amidation on the efficacy and selectivity of antimicrobial and anticancer peptides SR Dennison, F Harris, T Bhatt, J Singh, DA Phoenix Molecular and cellular biochemistry 332, 43-50, 2009 | 79 | 2009 |